Taipei Medical University/ National Taiwan University

Taipei Medical University/ National Taiwan University

TAIPEI MUNICIPAL WANFANG HOSPITAL(MANAGED BY TAIPEI MEDICAL UNIVERSITY)

Wanfang Hospital Continue to actively recruit medical elites, strengthen the medical level, establish tuberculosis centers, cancer centers, cancer hyperthermia centers, stroke centers, integrated Chinese and Western integrated care centers for pain, burns and difficult wounds, laser cosmetology centers, ... and other developments with unique characteristics

Wanfang Hospital provides not only professional medical services, but also patient-centered holistic care. Helping patient to recover their health、maintain their health, and promote their health is the most important thing to u

Taipei Veterans General Hospital

cancer treatment

Taipei Veterans General Hospital Center for Geriatrics and Gerontology

Taipei Veterans General Hospital Yuanshan Branch、National Taipei University of Technology

As Taiwan enters an aging society, the increase in the use of drips and urine bags will cause a large burden on medical staff. In response to this situation, this project developed a smart liquid level sensing device and smart monitoring system. The completed projects are as follows:

1.Develop mini liquid level measurement device and integrates low-power wireless communication system which send information to monitoring repeater.
2.Develop an APP to display the usage status of the device in real time through the account login interface, Integrate user\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s ID for uploading to cloud database, information shown on apps includes: conditions、device ID、liquid level、device mode and power.
3.Develop a cloud database with time record function, which can provide medical staff for follow-up data analysis based on historical records.
4. Develop a monitoring system APP, this system can obtain all device data from the cloud database.
5. Develop a dedicated APP, after logging in to the account, monitor the patient\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s drip and urine bag usage.

Using this system will effectively monitor and manage the drip and urine bag use of each patient, reduce the workload of medical staff, improve medical satisfaction, and improve medical-patient relationship and safety.

Taipei Veterans General Hospital, National Yang-ming University, National Chiao Tung University, Nat

Retinal diseases are the main cause of blindness, including senile retinal degeneration, diabetic retinopathy, and hereditary retinopathy. The angiogenesis of severe macular degeneration can only be treated with regular intraocular injection of anti-angiogenesis drugs, but it cannot be effectively treated. Luxturna, the first gene therapy drug, used an adenovirus-like virus that carried alleles to treat hereditary retinal disease-Lieber's Congenital Amaurosis (LCA). However, the efficacy of gene therapy with viral vectors cannot be sustained, and patients have to bear the risk of surgery repeatedly, which is the biggest disadvantage. CRISPR editing is the hope of treating retinopathy, but this novel technology is still a considerable challenge in retinal diseases. Nano-medicine-based nanoparticles can safely and effectively deliver the CRISPR-cas9 system, and repeat the treatment by intravitreal injection, which is a new treatment strategy.
This project combines leading nanoscience scholars and ophthalmologists to develop a precise nanogene therapy platform for hereditary retinopathy. It can be developed into a nanomedicine product with clinical application potential. It is expected that nano-gene therapy drugs can be successfully developed to build a basis for clinical trials in Taiwan and achieve the medical purpose of improving visual quality.

Taipei Veterans General Hospital/ National Yang-Ming University

Age-related macular degeneration exert impact on the vision of elderly people. The most problematic issue to treat AMD is the loss of retinal pigment epithelium (RPE) cells and the invasion of new blood vessels. To date, there is no clinically effective treatment, and RPE cells can be produced in vitro from mesenchymal stem cells, embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC). iPSC has attracted much attention due to its therapeutic potential. Although Japan has completed human trials of iPSC-RPE transplantation, it still cannot restore the eyesight of patients due to impaired Bruch’s membrane. We developed a biomimetic cell scaffold on polydimethylsiloxane (PDMS) as a repair material for Bruch's membrane, which can also be attached and grown by iPSC-derived RPE cells. We also introduced cylindrical micro-pillars into the back of the biological scaffold. It aims to provide high resistance to movement of tissue engineered RPE cell sheets grown on biological scaffolds. In order to prevent the invasion of new blood vessels, we have further established a drug slow-release coating on the stent, which can effectively inhibit angiogenesis. Based on the above advantages, the multifunctional implantable retinal bio-scaffold system developed has potential application in the treatment of wet AMD.

Taiwan Advanced Nanotech Inc.

Maelstrom 4800 Automated Extraction Instruments
Maelstrom 9600 Automated Extraction Instruments

Taiwan Advanced Nanotech Inc.

Maelstrom 4800 Automated Extraction Instruments
Maelstrom 9600 Automated Extraction Instruments